TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Beyond Meat Lead
Play
INVESTING

Top Shorted Stocks by Short Interest: Beyond Meat, SunPower

  • By Danny Peterson
  • Mar 19, 2021 2:32 PM EDT
Gogo Inflight Internet Lead
INVESTING

Most Heavily Shorted Stocks by Float Shorted: PubMatic, Gogo

  • By Danny Peterson
  • Feb 25, 2021 9:45 PM EST
PRESS RELEASES

Esperion To Report Fourth Quarter And Full Year 2020 Financial Results February 23, 2021

  • By GlobeNewswire
  • Feb 9, 2021 8:00 AM EST
PRESS RELEASES

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  • By GlobeNewswire
  • Jan 29, 2021 5:00 PM EST
PRESS RELEASES

ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results And Further Commits To Unmet Patient Needs With Oral PCSK9 Inhibitor Program

  • By GlobeNewswire
  • Jan 13, 2021 6:26 AM EST
PRESS RELEASES

First-in-class Cholesterol-lowering Treatment NILEMDO® * (bempedoic Acid) Tablet And Its Combination With Ezetimibe NUSTENDI® * (bempedoic Acid And Ezetimibe) Tablet Approved In Switzerland

  • By GlobeNewswire
  • Dec 16, 2020 3:00 AM EST
PRESS RELEASES

Esperion Launches U.S. Direct-to-Consumer Campaign To Accelerate Awareness Of NEXLETOL® (bempedoic Acid) Tablets And Increase Awareness Of Bad Cholesterol

  • By GlobeNewswire
  • Sep 28, 2020 4:06 PM EDT
China's Technology Start-ups Make A Spectacular Comeback From The Dog House Of The 2015 Stock Market Rout
JIM CRAMER

Coronavirus and Your Portfolio: Cramer's 'Mad Money' Recap (Tuesday 2/25/20)

  • By Scott Rutt
  • Feb 25, 2020 8:31 PM EST
Dow Futures Push Further Into Record Highs as Trump Signals China Trade Progress
JIM CRAMER

Tsunami of Innovation: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Nov 21, 2019 8:59 PM EST
AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
JIM CRAMER

AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Nov 21, 2019 8:39 PM EST
3 Cutting-Edge Biotech Stocks That Can Double in Value
STOCKS

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

  • By Kinsey Grant
  • Mar 20, 2018 2:58 PM EDT
Delta Soars on Better-Than-Expected Profit, Revenue Offsetting Fuel Costs
JIM CRAMER

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Oct 17, 2017 9:27 PM EDT
Best and Worst Closed-End Funds
JIM CRAMER

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 17, 2017 9:14 PM EDT
Apple Gains Put Dow on Track for Sixth Straight Record Close
JIM CRAMER

Markets Focus on Business: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Aug 28, 2017 8:11 PM EDT
3 Health Care Stocks to Own for 2017
HEALTH

Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks

  • By Armie Margaret Lee
  • Jul 14, 2017 4:11 PM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

  • By Armie Margaret Lee
  • Jun 29, 2017 9:26 AM EDT
Apple iPhone Shipment Estimates Slashed by 11 Million, Bank Sees 3-4 Week Delay in New Smartphone
STOCKS

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

  • By Roberto Pedone
  • Jun 9, 2017 1:19 PM EDT
Alibaba Open at Record High as Investors Go Berserk After Sales Forecasts Crush Estimates
JIM CRAMER

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Apr 11, 2017 6:20 AM EDT
One of Caterpillar's Most Important Measures Is Rising, Which Could Help Send the Stock Up 15%
JIM CRAMER

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Apr 11, 2017 6:11 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: Esperion, Minerva and BioCryst

  • By Armie Margaret Lee
  • Mar 21, 2017 9:32 AM EDT
AMD Shares Plunge on Q3 Earnings and Revenue Miss
STOCKS

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

  • By Jonas Elmerraji
  • Mar 20, 2017 2:03 PM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: CytomX, Aevi, Esperion

  • By Armie Margaret Lee
  • Mar 20, 2017 9:35 AM EDT
AveXis, Esperion and Amgen Among Biotech Movers
HEALTH

AveXis, Esperion and Amgen Among Biotech Movers

  • By Armie Margaret Lee
  • Mar 17, 2017 11:03 AM EDT
What Tax Reform Means for PayPal's Bottom Line
JIM CRAMER

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Feb 28, 2017 6:20 AM EST
Why Billionaire Warren Buffett Has Dumped IBM Shares And Loaded Up on Apple
JIM CRAMER

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Feb 28, 2017 6:15 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.